null hypothesis

Related by string. * NULL . nulls . nulled . nulling . Nulls . Null : null void . null responders . unconstitutional null . declared null . null responder HCV . quarterback Keith Null . rookie Keith Null . Rookie Keith Null / Hypothesis : plausible hypothesis . savanna hypothesis . hypothesis posits . Astonishing Hypothesis . Happiness Hypothesis . Gaia hypothesis . Gaia Hypothesis . amyloid hypothesis * *

Related by context. All words. (Click for frequent words.) 64 chi squared 63 Bonferroni 62 regression coefficients 61 noninferiority 61 univariate analyzes 61 statistical significance p 61 MMSE score 60 MDRD 60 Bonferroni correction 60 univariate 60 correlational 60 χ 59 logistic regression models 59 interobserver reliability 59 logistic regression model 59 logistic regression 59 residual confounding 59 confidence intervals CIs 59 variance ANOVA 59 multivariable Cox 59 multivariate Cox 59 correlation coefficients 59 nonzero 59 ANOVA 59 nonparametric 59 intact parathyroid hormone 58 conditional logistic regression 58 multivariate analyzes 58 HOMA IR 58 bivariate 58 factorial 58 covariate 58 Kaplan Meier analysis 58 logistic regression analyzes 57 periprocedural MI 57 Pearson correlation coefficient 57 numerosity 57 Kruskal Wallis test 57 priori 57 thyroglobulin 57 NIHSS score 57 multivariable analysis 57 Descriptive statistics 57 empiric 57 pairwise comparisons 57 MDRD equation 57 Correlation coefficients 57 mere scintilla 57 testable hypothesis 57 Wilcoxon rank sum 56 d dimer 56 σ 56 convergent validity 56 meta analytic 56 sensitivity specificity 56 HER2 expression 56 logistic regression analysis 56 anthropogenic warming 56 logit 56 albumin excretion 56 allele frequencies 56 generalized linear 56 unmeasured confounders 56 Pearson correlation coefficients 56 intraclass correlation coefficient 56 dichotomized 56 pairwise 56 multiplicative 56 pCR 56 ± SEM 56 μmol L 56 covariance 55 creatinine ratio 55 Kaplan Meier curve 55 regression coefficient 55 % Confidence Interval 55 attain statistical significance 55 surrogate endpoint 55 Sensitivity analyzes 55 Logistic regression 55 nmol liter 55 inferential statistics 55 Gaussian distribution 55 covariance ANCOVA 55 retest reliability 55 ρ 55 TOP2A 55 empirically testable 55 Eq. 55 estimated GFR 55 albumin excretion rate 55 teleology 55 unpaired t 55 univariate analysis 55 heritable variation 55 macroevolution 55 pure fructose 55 HbA 1c 54 CR nPR 54 ASCUS 54 #F FDG PET 54 F FDG PET 54 familial aggregation 54 multiple linear regression 54 methodologic 54 statistical significance 54 subgroup analyzes 54 nonrandomized studies 54 CI -#.# 54 lipoprotein levels 54 linear regression analysis 54 ADAS cog 54 stepwise logistic regression 54 multivariate regression 54 prospectively defined 54 hypothesis 54 glomerular filtration rate 54 generalized estimating 54 DAS# remission 54 bivariate analysis 54 Non inferiority 54 falsifiability 54 leukocyte count 54 lumbar spine BMD 54 methodological naturalism 54 subclinical hyperthyroidism 54 ROC curves 54 epistasis 54 odds ratios ORs 54 multiple logistic regression 53 pretest probability 53 Subgroup analyzes 53 posttreatment 53 Hb A1C 53 Poisson regression 53 predictive validity 53 baseline HbA1c 53 albumin creatinine ratio 53 Mantel Haenszel 53 syndromal 53 Multiple linear regression 53 nucleotide substitutions 53 Bayes Theorem 53 Multivariate analysis 53 invariance 53 Bulk density 53 interrater reliability 53 cTnI 53 Supplementary Table 53 scientifically testable 53 SUVmax 53 Repeatability 53 irreducible complexity 53 antibody titer 53 multivariate logistic regression 53 serum HBV DNA 53 surrogate markers 53 PSA nadir 53 prognostic significance 53 creatinine clearance 53 adnexal mass 53 multivariable adjusted 53 prespecified 53 carotid IMT 53 IV bisphosphonates 53 Kaplan Meier survival 53 OGTT 53 regression analyzes 53 linear extrapolation 53 perturbation theory 53 posttest 53 heterozygotes 53 mRS 53 interobserver 53 θ 53 aldosterone antagonist therapy 53 clinicopathological 53 neo Darwinism 53 ALT elevation 53 definite stent thrombosis 53 statistically significant p = 53 falsifiable 53 ontologically 53 corrected QT interval 53 aminotransferase levels 53 neo Darwinian evolution 53 noninferior 53 nomogram 53 biologic plausibility 53 objectively verifiable 53 intraobserver 53 cranial irradiation 53 ANCOVA 53 bivariate analyzes 53 fermion 52 intima media thickness 52 plasma cortisol 52 p = #.# [003] 52 plasma glucose concentration 52 causal inferences 52 serum CRP 52 hemoglobin Hb 52 mammographic density 52 D dimer 52 τ 52 nomograms 52 polygenic 52 #ng/ml 52 empirical observation 52 immunohistochemical analysis 52 AGW theory 52 morphometric vertebral fractures 52 postintervention 52 nonresponders 52 -#.# ± [002] 52 nonfasting 52 chemosensitivity 52 κ 52 serum PSA 52 Glomerular filtration rate 52 ε 52 HbA 1c levels 52 clinically insignificant 52 P/E# 52 ß = 52 differential gene expression 52 sphericity 52 Mendelian inheritance 52 eosinophil count 52 Cronbach alpha 52 psychiatric comorbidity 52 HIV tropism 52 subthreshold 52 SLNB 52 ascertainment bias 52 etiologic 52 PITX2 methylation 52 glutamate glutamine 52 p = .# [002] 52 categorical variables 52 exhaled nitric oxide 52 nonsignificant 52 lipoprotein cholesterol 52 LV hypertrophy 52 evolvability 52 probabilistic methods 52 bronchial responsiveness 52 imply causation 52 mechanistic explanation 52 linkage disequilibrium 52 skewness 52 HbA1C 52 Bayes theorem 52 adjuvant systemic 52 Reynolds Risk Score 52 mcg dose 52 reliabilities 52 dopamine transporter gene 52 probabilistically 52 intraclass correlation coefficients 52 confounder 51 pg mL 51 β blockers 51 kurtosis 51 adiponectin concentrations 51 observable phenomena 51 gadobutrol 51 asymptotic 51 tHcy 51 gravitational redshift 51 HBeAg seroconversion 51 Kaplan Meier method 51 stoichiometry 51 = -#.# 51 disproof 51 Fig. 3b 51 ARB telmisartan 51 entirely Maeir 51 optimality 51 hip resurfacing arthroplasty 51 secondary efficacy endpoint 51 testable theories 51 PSQI 51 magnon 51 linear regression 51 fig. S1 51 ideality 51 Young modulus 51 viral kinetics 51 virginity pledgers 51 empirically verified 51 fractal dimension 51 artifactual 51 Rating Scale BPRS 51 inhibin B 51 generalisable 51 histologic subtype 51 Hazard Ratio HR 51 microevolution 51 generalizability 51 causal inference 51 biochemical recurrence 51 methodological flaws 51 NIHSS 51 CORE OM 51 Appellant asserts 51 antioxidant supplementation 51 Randomized clinical trials 51 anthropic 51 adiponectin levels 51 APOE genotype 51 Kaplan Meier curves 51 lognormal 51 endometrial thickness 51 apolipoprotein B 51 Theoretical calculations 51 enthalpy 51 % CI #.#-#.# [004] 51 logarithm 51 neostigmine 51 nonfasting triglyceride levels 51 μg dL 51 Evolutionary theory 51 mmol l 51 adenoma recurrence 51 selenium supplementation 51 regression equations 51 serum estradiol 51 microdose 51 cTnT levels 51 Genotypic 51 mL/min/#.# m 2 51 mmol L 51 rho = 51 statistical probabilities 51 multivariable logistic regression 51 #.#ng/ml 51 mITT 51 virological response 51 ω 51 TNSS 51 galaxy redshift 51 preoperative PSA 51 IDers 51 Kaplan Meier 51 binary logistic regression 51 elevated CRP 51 z = 51 multivariate regression analysis 51 BPH Symptom Score 51 echocardiographic parameters 51 EDSS score 51 HbA1C levels 51 nmol L 51 Y BOCS 51 atherogenic 51 hemoglobin A1c levels 51 quantile 51 plasma pharmacokinetics 51 androgen suppression 51 r2 = 51 biopsy Gleason 51 nondiabetics 51 unanimity instruction 51 methacholine challenge 51 spirometric 51 dyssynchrony 51 sd = 51 kidney allograft 51 fig. S2 51 PSA kinetics 51 titrated glipizide 50 histopathological 50 serum calcium 50 FEV ^ sub 50 eplerenone 50 generalisability 50 urine albumin 50 APOC3 50 virologic failure 50 mIU L 50 amyloid cascade 50 β = 50 imply causality 50 cTnT 50 ICD implantation 50 TIMP 1 50 coexpression 50 lowering homocysteine 50 troponin T 50 scientifically valid 50 WOMAC pain 50 authors hypothesized 50 ADAS Cog 50 inductive reasoning 50 baseline FEV1 50 mcg mL 50 QTc 50 penetrance 50 fasting triglycerides 50 FeNO 50 Ejection Fraction 50 autocorrelation 50 NAbs 50 myocardial viability 50 hypogonadal 50 parameter estimation 50 mg kg dose 50 baseline FEV 50 Fig. 4a 50 dichotomous variables 50 CIN3 50 serum creatinine levels 50 NHANES III 50 peak VO2 50 serum albumin 50 Response Evaluation Criteria 50 elastic modulus 50 amyloid hypothesis 50 clinicopathological features 50 tPSA 50 metabolic parameters 50 serum uric acid 50 construal 50 Univariate 50 ABC/3TC 50 -#.# ± [001] 50 metabolite concentrations 50 tertiles 50 A1c levels 50 resonance frequency 50 statistical correlations 50 biological plausibility 50 Haptoglobin 50 KRAS mutation status 50 corneal thickness 50 ECLS 50 Cardiorespiratory fitness 50 strontium ranelate 50 proportional hazards 50 radians 50 blackbody 50 electrophysiologic 50 HbA 1C 50 subclinical hypothyroidism 50 osmolality 50 ontogenetic 50 Neo Darwinism 50 KRAS variant 50 mmol L. 50 reasonable factfinder 50 HGPIN 50 anogenital distance 50 Gram stain 50 periprocedural 50 CYP#D# genotype 50 cosmological models 50 mean ± SEM 50 chest radiographs 50 EROEI 50 logistic regressions 50 CSF biomarkers 50 finite element method 50 FDA defined valvulopathy 50 unmeasured confounding 50 irbesartan 50 advanced adenoma 50 reactance 50 #Gy 50 log# copies mL 50 cystatin C 50 AST ALT 50 radiographic progression 50 carotid plaque 50 mITT population 50 serum urate levels 50 surrogate marker 50 serum HCV RNA 50 KRAS mutation 50 plain radiographs 50 CALJIC No. #.# 50 gambler fallacy 50 thyrotropin levels 50 gross disproportionality 50 unfractionated heparin 50 neo Darwinian 50 dietary modification 50 collectivist cultures 50 rHuEPO 50 GIK infusion 50 prespecified criteria 50 radical nephrectomy 50 clinically meaningful differences 50 δ 50 post hoc 50 prognostic indicator 50 metaanalysis 50 unfalsifiable 50 Crohn Disease Activity 50 corneal staining 50 multinomial 50 correlations 50 mutated K ras 50 PSA velocity 50 CVD mortality 50 EQ 5D 50 calculated creatinine clearance 50 hierarchical clustering 50 HSCT 50 locoregional recurrence 50 monotonically 50 endoxifen 50 homocysteine concentrations 50 symptom exacerbation 50 platelet reactivity 50 empirical 50 AUA Symptom Score 50 premorbid 50 explanatory variables 50 brachial blood 50 Cpk 50 arterial thickening 50 SNe Ia 49 histologic diagnosis 49 serum magnesium 49 LDL HDL 49 grade interpolation 49 Score IPSS 49 neutrino oscillation 49 somatoform disorders 49 stepwise regression 49 fetal malformations 49 Sensitivity specificity 49 mathematical calculation 49 USPSTF 49 immunohistochemical 49 lymphadenectomy 49 dichotomous variable 49 FDG PET CT 49 chi ^ sup 49 ZephirAWT 49 oocytes retrieved 49 monozygotic twins 49 BEIR VII 49 multivariable regression 49 confidence interval #.#-#.# 49 wavefunction 49 neutrophil counts 49 cytologic 49 borderline statistical significance 49 coronary stenosis 49 Cytogenetic 49 NOAEL 49 EBMT criteria 49 fluorescence intensity 49 formulate hypotheses 49 microg 49 transient elastography 49 procedural unconscionability 49 K ras mutations 49 urinary BPA 49 methotrexate monotherapy 49 CHD mortality 49 prion hypothesis 49 corneal curvature 49 core needle biopsies 49 bimodal distribution 49 pg ml 49 Pascal Wager 49 Randomized trials 49 corneal astigmatism 49 ACCORD Lipid 49 TEXT OMITTED FROM SOURCE 49 kcal mol 49 genotypic 49 DXA scan 49 postoperative radiographs 49 axial length 49 φ 49 disconfirm 49 Logistic regression analysis 49 urinary calcium 49 clinico pathological 49 Einstein relativity theory 49 incommensurability 49 Heisenberg principle 49 methodological individualism 49 serum vitamin D 49 meta analyzes 49 eGFR 49 interobserver agreement 49 hysteresis loop 49 plasma lipid 49 figs. 49 complete cytogenetic response 49 Multiple logistic regression 49 MetS 49 diffusivity 49 semiquantitative 49 serum homocysteine 49 carotid stenosis 49 avosentan 49 nonobese 49 extensive metabolizers 49 warfarin dose 49 protein conformation 49 seropositivity 49 glomerular filtration 49 hMG 49 virologic response 49 HORIZONS AMI trial 49 serum urate 49 histopathologic findings 49 coronary CTA 49 serum concentrations 49 mIU ml 49 RfD 49 autoregulation 49 PUFA intake 49 tumor histology 49 Histologic 49 multivariate adjustment 49 mrad 49 reversibility 49 LV dysfunction 49 FDG uptake 49 purely naturalistic 49 hydroxy vitamin D 49 interrater 49 manifestly erroneous 49 theistic evolution 49 Cockcroft Gault 49 thromboprophylaxis 49 genetic relatedness 49 Dirac fermions 49 reboxetine 49 microalbuminuria 49 rs# [002] 49 Newtonian mechanics 49 elevated LDH 49 logical fallacy 49 = .# 49 treat NNT 49 androgen deprivation 49 prespecified secondary 49 λ 49 parol evidence 49 -#.# log# 49 per deciliter mg 49 aneuploidy 49 apolipoproteins 49 silent myocardial ischemia 49 nmol L. 49 counterfactual 49 DAS# scores 49 efficacy endpoint 49 aPTT 49 equipotent 49 vitreous haze 49 idraparinux 49 HDRS 49 EUS FNA 49 ± SD 49 quadratic 49 standard deviations 49 topo II 49 NPH insulin 49 CCyR 49 fructosamine 49 aneuploid 49 unmeasured factors 49 pathophysiological 49 NNRTI resistance 49 epistemic 49 histopathologic 49 reach statistical significance 49 LS BMD 49 confidence interval CI 49 % CI #.#-#.# [001] 49 g cm 49 Pred Forte 49 primary aldosteronism 49 PSADT 49 EBRT 49 apoptosis pathway 49 NP CRNs 49 CHADS2 49 § #-#.# [002] 49 DHEA supplementation 49 hsCRP 49 atorvastatin #mg 49 causation 49 #:#-# [002] 49 alteplase 49 recurrent VTE 49 DULERA 49 % CI #.#-#.# [006] 49 sentinel nodes 49 microsatellite instability 49 gravimetric method 49 DSM IV diagnosis 49 η 49 MTT assay 49 dizygotic twins 49 % CI #.#-#.# [005] 49 subscore 49 rs# [004] 49 vasopressor 49 virological failure 49 genomewide 49 allelic 49 dose proportionality 49 cardiac troponin T 49 System IPSS 49 postmenopausal hormones 49 International Prostate Symptom 49 subclinical atherosclerosis 49 Cmax 49 thyroid stimulating hormone 48 Linear regression 48 bronchoalveolar lavage 48 Index CDAI 48 mg BID dose 48 MTHFR gene 48 definitionally 48 nonfatal MI 48 dosimetric 48 serum IGF 48 Bojowald 48 lactate dehydrogenase 48 FDG PET 48 IOP lowering 48 noncardiac 48 Solid Tumors RECIST 48 sentinel lymph node biopsy 48 CDAI score 48 achieved statistical significance 48 sUA 48 PNH patients 48 #.# df = 48 ExTRACT TIMI 48 LV ejection fraction 48 binomial model 48 probabilities 48 QRS width 48 endoscopic gastric ulcers 48 Flow cytometry 48 forcings 48 valvulopathy 48 prostate cancer CaP 48 PD2i R 48 Multivariate 48 response pCR 48 variograms 48 discriminant analysis 48 beta blocker therapy 48 NNT = 48 VKORC1 48 HLA G 48 laterality 48 ECOG PS 48 Younger abstention 48 inotropic agents 48 adenoma detection 48 angiographically 48 chronicity 48 racemic mixture 48 Eur Urol 48 Å -1 48 nonmovant 48 comorbidity 48 clinicopathologic 48 theoretic 48 Radiometric dating 48 avoidant personality disorder 48 Hole IKD 48 hypochondriasis 48 Neuropsychiatric Inventory NPI 48 hippocampal atrophy 48 teleological 48 posteriori 48 propter hoc 48 overbreadth 48 prospectively randomized 48 Newtonian gravity 48 hematopoietic cancers 48 antihypertensive therapy 48 infantile colic 48 prognostically 48 alexithymia 48 #OHD 48 #.#,#.# [002] 48 Reproducibility 48 octanol 48 unvalidated 48 pathophysiologic 48 Regression analysis 48 familial AF 48 μg kg 48 plasma homocysteine 48 PCa 48 CIN2 48 ng mL 48 nonpregnant women 48 monism 48 Pharmacokinetic parameters 48 FDG-PET/CT 48 Einstein equations 48 DMARD 48 serum biomarkers 48 pleiotropy 48 serum testosterone 48 KRAS mutations 48 tau mutation 48 SCr 48 neurodevelopmental impairment 48 atherosclerotic renal artery stenosis 48 therapeutic equivalence 48 LOCF 48 fFN 48 predefined criteria 48 untestable 48 symptomatic VTE 48 retrograde extrapolation 48 oral anticoagulation 48 Unified Parkinson Disease 48 karyotype 48 hydroxyvitamin D levels 48 elevated homocysteine 48 genotypic resistance 48 thyrotropin 48 #.#mg/dL 48 serum thyroglobulin 48 PLCO 48 alanine aminotransferase ALT 48 RQ PCR 48 proton radius 48 immunoglobulin G 48 subanalysis 48 carotid bruit 48 postmenopausal estrogen 48 PITX2 48 rheumatoid factor 48 methodological differences 48 logarithmic scale 48 serotonin deficiency 48 Orthostatic hypotension 48 = #.#-#.# 48 Bayesian probability 48 neoadjuvant chemotherapy 48 vitamin D sufficiency 48 elasticities 48 paricalcitol 48 hormone receptor status 48 specific antigen PSA 48 airway responsiveness 48 Ishak fibrosis score 48 HIV RNA 48 serum lipid 48 monophasic 48 RCTs 48 indels 48 ACI TIPI 48 aspartate aminotransferase AST 48 search ellipsoid 48 perfusion abnormalities 48 linear regression analyzes 48 AUCs 48 SVR# 48 cognitive distortions 48 ROC curve 48 CTEPH 48 XIENCE V PROMUS Stent 48 poly L lysine 48 eNO 48 pmol L 48 genes CYP#C# 48 nephrectomy 48 lymph node metastasis 48 summative 48 OPRM1 48 mmHg p = 48 stochastically 48 undetectable HBV DNA 48 ORS #B.# 48 nucleotide sequence 48 Multivariate logistic regression 48 thickness CIMT 48 APOE ε4 48 postprocedure 48 Math LD 48 Oncotype DX Recurrence Score 48 non pharmacological interventions 48 parasitaemia 48 LVEF 48 PCWP 48 Doxil ® 48 oxygen isotope 48 syllogism 48 N glycan 48 Intermountain Risk Score 48 Empirically 48 IL#B 48 True thicknesses 48 Einstein theories 48 phenotypic expression 48 cardiac troponin 48 stoichiometric 48 neuroanatomical 48 geoid 48 refractive correction 48 nmol l 48 serum retinol 48 interferon alfa 2b 48 pulmonary arterial 48 statistically nonsignificant 48 maturational 48 prejudice prong 48 liver metastasis 48 KRAS status 48 serologic 48 baseline LDH 48 nitrotyrosine 48 adjunctive ABILIFY 48 HPA axis suppression 48 overt hypothyroidism 48 IPCC AR4 48 Viral load 48 perioperative mortality 48 CsA 48 MMSE scores 48 #mg dose [003] 48 permanently discontinue Vectibix 48 tocilizumab 48 presuppositions 48 Post hoc ergo 48 estrogen receptor ER 48 multivariate adjusted 48 ejection fractions 48 lymphocyte count 48 IGRAs 48 ICRP 48 urinary N telopeptide 48 Montgomery Åsberg Depression 48 Subgroup analysis 48 AUC0 48 Primary endpoints 48 thiopurine 48 ATACAND 48 Kruskal Wallis 48 achieve statistical significance 48 isoprostane 48 ELBW infants 48 Alternative splicing 48 histologic subtypes 48 Interrater reliability 48 CK MB 48 nanograms milliliter 48 thrombosis embolism 48 dephasing 48 TT genotype 48 kriging 48 prognostic variables 48 X chromosome inactivation 48 CI #.#-#.# [001] 48 SerDes transceivers 48 diuretic chlorthalidone 48 punctuated equilibrium 48 ivabradine 48 SRBD 48 mechanistically 48 Darwinian Theory 48 ventricular dyssynchrony 47 elastic moduli 47 CC genotype 47 PVS diagnosis 47 Scale cognitive subscale 47 Darwinian evolution 47 stochasticity 47 antipsychotic efficacy 47 JILA scientists 47 histopathologic examination 47 HER2 amplification 47 biochemical relapse 47 quantifications 47 Lorentzian 47 glycosylated hemoglobin HbA1c 47 Leydig cell 47 Genetic variation 47 testable prediction 47 postoperative mortality 47 tapentadol ER 47 Hemoglobin A1c 47 reinfarction 47 causative 47 t/m3 47 transabdominal 47 morphologic 47 plainly erroneous

Back to home page